President of Phadia US Inc. Killed in Plane Crash
Published: Jul 07, 2009
PORTAGE, Mich.--(BUSINESS WIRE)--Michael Land, President of Phadia US Inc, the world leader in in vitro allergy diagnostics and manufacturer of ImmunoCAP Specific IgE blood testing, died yesterday when the Columbia Aircraft LC41 he was piloting crashed at about 1 p.m., after taking off from Tri-State Airport, in Huntington, West Virginia. His 23 year old son, Drew, was also killed in the plane crash. Business Wire - Michael Land, who was killed in a plane crash on Sunday, was President of Phadia U.S. Under ...
Business Wire - Michael Land, who was killed in a plane crash on Sunday, was President of Phadia U.S. Under ...
Mr. Land was returning home to Michigan after visiting family with his wife and two sons over the July 4th weekend. Mr. Land and his elder son were returning in Michael's plane. Mr. Land is survived by his wife, Nancy and his son, Zach, who were returning to Michigan separately by car.
Mr. Land enjoyed a 20-year career with Phadia, during which time he ascended from a sales role to President of the company’s U.S. operations in 1996. His leadership drove Phadia’s U.S. growth by double digits in each of the past 9 years, establishing the company’s ImmunoCAP business as the leading in vitro IgE test in the United States. Michael’s leadership and impact were felt broadly across the marketplace and his efforts had a positive impact on patient care based on the growing utilization of in vitro allergy testing in the United States.
Magnus Lundberg, Chief Executive Officer of Phadia AB, will lead the US operations until a permanent successor to Mr. Land is named. In commenting on the tragedy, Mr. Lundberg said, “The entire Phadia team mourns the loss of Michael Land, and our heart goes out to the Land family. Michael was a wonderful human being – a hard working and visionary leader and devoted father and husband. His leadership, upbeat personality, and charisma will be sorely missed by everyone at Phadia.”
The National Transportation Safety Board is investigating the accident. Further details are expected as the investigation continues.
Phadia AB, headquartered in Uppsala, Sweden, is the world leader in in vitro IgE diagnostic research and product development. Its U.S. affiliate, Phadia US is headquartered in Portage, Michigan. For more information on Phadia or ImmunoCAP, please visit http://www.isitallergy.com/.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid6001049<=en
MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6001049